Page 43 - SOGIBA 1 2020
P. 43
Tumores ováricos secretores de andrógenos
REFERENCIAS
• Barbieri RL, Smith S, Ryan KJ. The role of • Souto SB, Baptista PV, Braga DC, Carvalho D.
hyperinsulinemia in the pathogenesis of ova- Ovarian Leydig cell tumor in a post-menopausal
rian hyperandrogenism. Fertility and Sterili- patient with severe hyperandrogenism. Arq Bras
ty 1988 50 197–212. Endocrinol Metabol. 2014;58:68–75.
• Haroon S, Zia A, Idrees R, Memon A, Fatima S, • Sakamoto K, Fujimitsu R, Ida M, Horiuchi S,
Kayani N. Clinicopathological spectrum of ova- Hamada Y, Yoshimitsu K. MR diagnosis of steroid
rian sex cord-stromal tumors; 20 years’ retros- cell tumor of the ovary: value of chemical shift
pective study in a developing country. J Ovarian imaging. Magn Reson Med Sci. 2009; 8:193–195.
Res. 2013;6:87. • Montoriol PF, Mons A, Da Ines D, Bourdel N,
• Shim SH, Kim DY, Lee SW, et al. Laparoscopic ma- Tixier L, Garcier JM. Fibrous tumours of the
nagement of early-stage malignant non-epithelial ovary: aetiologies and MRI features. Clin Ra-
ovarian tumors: surgical and survival outco- diol. 2013;68:1276–1283.
mes. Int J Gynecol Cancer. 2013;23:249–255. • Outwater EK, Wagner BJ, Mannion C, McLarney
• Jung SE, Rha SE, Lee JM, et al. CT and MRI fin- JK, Kim B. Sex cord-stromal and steroid cell tu-
dings of sex cord-stromal tumor of the ovary. Am mors of the ovary. Radiographics. 1998;18:1523–
J Roentgenol. 2005;185:207–215. 1546
• Pratt J. Pathology of the ovary. 1st ed. Philadel- • Young RH, Path FRC, Scully RE. Sex cord-stromal,
phia: Sounders; 2004. pp. 197–226. steroid cell, and other ovarian tumors with endo-
• Kurman RJ, Carcangiu ML, Herrington CS, Young crine, paraendocrine, and paraneoplastic manifes-
RH. WHO Classification of Tumours. 4th ed. Vol. tations. In: Kurman RJ, ed. Blaustein’s pathology of
6. Lyon: IARC; 2014. Classification of tumours of the female genital tract. New York: Springer-Verlag
the ovary; pp. 44–56. 1994: 783–847.
• Olt G, Mortel R. Hormone-producing tu- • Young RH,Scully RE. Ovarian Sertoli–Leydig
mors of the ovary. Endocrine-Related Can- cell tumors. A clinicopathological analysis of 207
cer 1997 4 447–457. cases. American Journal of Surgical Patholo-
gy1985 9 543–569.
• Quirk JT , Natarajan N. Ovarian cancer incidence
in the United States, 1992–1999. Gynecologic • Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, Wa
Oncology 2005 97 519–523. n X, Xiang Y, Xiao Y , Guo L. A clinicopathological
analysis of 40 cases of ovarian Sertoli–Leydig cell
• Takeuchi S, Ishihara N, Ohbayashi C, Itoh H , Ma-
tumors.Gynecologic Oncology 2012 127 384–389.
ruo T. Stromal Leydig cell tumor of the ovary. Case
report and literature review. International Journal • Sigismondi C, Gadducci A, Lorusso D, Candia-
of Gynecological Pathology 1999 18 178–182. ni M, Breda E, Raspagliesi F,Cormio G, Mari-
naccio M , Mangili G. Ovarian Sertoli–Leydig cell
• Dunnihoo DR, Grieme DL , Woolf RB. Hilar-cell
tumors. a retrospective MITO study. Gynecologic
tumors of the ovary. Report of 2 new cases and
Oncology 2012 125 673–676.
a review of the world literature. Obstetrics and
Gynecology1966 27 703–713.
Volumen 99 - Nº 1007 - Agosto 2020 41